Oppenheimer & Co. Inc. lessened its holdings in Amdocs Limited (NASDAQ:DOX – Free Report) by 1.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 41,361 shares of the technology company’s stock after selling 664 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Amdocs were worth $3,618,000 as of its most recent SEC filing.
Several other large investors have also added to or reduced their stakes in DOX. State Board of Administration of Florida Retirement System increased its position in shares of Amdocs by 7.9% in the first quarter. State Board of Administration of Florida Retirement System now owns 166,927 shares of the technology company’s stock valued at $16,030,000 after acquiring an additional 12,178 shares during the last quarter. Boston Trust Walden Corp increased its position in shares of Amdocs by 17.0% during the 2nd quarter. Boston Trust Walden Corp now owns 618,387 shares of the technology company’s stock worth $48,803,000 after purchasing an additional 89,726 shares during the last quarter. SG Americas Securities LLC raised its stake in shares of Amdocs by 402.4% during the 2nd quarter. SG Americas Securities LLC now owns 154,968 shares of the technology company’s stock worth $12,230,000 after purchasing an additional 124,122 shares in the last quarter. Sargent Investment Group LLC acquired a new stake in shares of Amdocs in the 2nd quarter valued at approximately $289,000. Finally, Acadian Asset Management LLC grew its stake in shares of Amdocs by 22.7% in the first quarter. Acadian Asset Management LLC now owns 1,395,894 shares of the technology company’s stock valued at $126,119,000 after buying an additional 258,343 shares in the last quarter. Institutional investors and hedge funds own 92.02% of the company’s stock.
Amdocs Price Performance
Shares of NASDAQ DOX opened at $83.98 on Friday. The firm has a market capitalization of $9.87 billion, a P/E ratio of 19.81, a P/E/G ratio of 1.42 and a beta of 0.74. The firm’s 50-day moving average price is $88.18 and its 200-day moving average price is $83.96. The company has a current ratio of 1.24, a quick ratio of 1.24 and a debt-to-equity ratio of 0.21. Amdocs Limited has a 1-year low of $74.41 and a 1-year high of $94.04.
Amdocs Announces Dividend
Analysts Set New Price Targets
A number of equities research analysts have recently issued reports on the stock. Oppenheimer upped their target price on shares of Amdocs from $98.00 to $105.00 and gave the company an “outperform” rating in a report on Wednesday. Stifel Nicolaus assumed coverage on Amdocs in a report on Wednesday, October 2nd. They set a “buy” rating and a $100.00 target price for the company. StockNews.com cut Amdocs from a “strong-buy” rating to a “buy” rating in a research note on Thursday. Finally, Barclays decreased their price target on Amdocs from $113.00 to $111.00 and set an “overweight” rating on the stock in a research report on Thursday. One analyst has rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $101.83.
Check Out Our Latest Stock Report on DOX
Amdocs Profile
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Featured Articles
- Five stocks we like better than Amdocs
- Election Stocks: How Elections Affect the Stock Market
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- How to Invest in Biotech Stocks
- Top-Performing Non-Leveraged ETFs This Year
- What is the Australian Securities Exchange (ASX)
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX – Free Report).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.